RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation

Hiroyuki Shikuma, Keisuke Goto, Ayako Shimo, Tomoya Hatayama, Kazuma Yukihiro, Kyosuke Iwane, Ryoken Yamanaka, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, Kohei Kobatake, Yohei Sekino, Hiroyuki Kitano, Akihiro Goriki, Keisuke Hieda, Osamu Kaminuma, Nobuyuki Hinata · 2026

Read RIOK2 Promotes Clear Cell Renal Cell Carcinoma Progression Through Cell Cycle Regulation by Hiroyuki Shikuma, Keisuke Goto, Ayako Shimo, Tomoya Hatayama, Kazuma Yukihiro, Kyosuke Iwane, Ryoken Yamanaka, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, Kohei Kobatake, Yohei Sekino, Hiroyuki Kitano, Akihiro Goriki, Keisuke Hieda, Osamu Kaminuma, Nobuyuki Hinata (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13443129.txt.

Description

Shikuma and colleagues investigate RIOK2, a protein that helps build ribosomes, the cell's protein factories, as a driver of clear cell renal cell carcinoma, the commonest kidney cancer. Their 2026 study stains 166 tumor samples for the protein, checks gene data, and silences RIOK2 in lab cancer cells. They also test a drug that blocks the protein, checking whether it mimics silencing.

Tumors rich in RIOK2 were of higher stage and grade. Their patients had shorter cancer specific and progression free survival. That means less time until death or until the disease advanced. Silencing RIOK2 cut cell growth, invasion, and movement, and froze cells at the first stage of the division cycle, with less of a key cycle protein. Gene profiles after silencing showed cell cycle programs switched down. The blocking drug slowed cell growth in proportion to dose, backing RIOK2 as a drug target.

Catalog record

CREATORHiroyuki Shikuma, Keisuke Goto, Ayako Shimo, Tomoya Hatayama, Kazuma Yukihiro, Kyosuke Iwane, Ryoken Yamanaka, Ryo Tasaka, Yuki Kohada, Kenshiro Takemoto, Kohei Kobatake, Yohei Sekino, Hiroyuki Kitano, Akihiro Goriki, Keisuke Hieda, Osamu Kaminuma, Nobuyuki Hinata
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13443129

Browse the full library · About the Tower of Babel